about
Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical TherapyThe prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.Psychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosisOnychomycosis in north-East of iran.Occult tinea pedis in an Israeli population and predisposing factors for the acquisition of the disease.Onychomycosis in patients with nail psoriasis: a point to point discussion.Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.Epidemiology and clinical classification of onychomycosis.Patients at risk of onychomycosis--risk factor identification and active prevention.Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.The prevalence of fungi in fingernail onychomycosis.Onychomycosis: beyond cosmetic distress.Toenail onychomycosis: current and future treatment options.Emerging therapeutic agents for onychomycosis.Ungual and transungual drug delivery.Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.Insights into drug delivery across the nail plate barrier.Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.Improving Cure Rates in Onychomycosis.Tavaborole - a treatment for onychomycosis of the toenails.Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria.Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification.How effective is efinaconazole in the management of onychomycosis?When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails.In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte molds involved in foot mycosis.Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.Quality of life in patients with toenail onychomycosis.Prevalence and Epidemiology of OnychomycosisThe Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature
P2860
Q26771955-37921746-0A44-4349-B81E-64A951EBADEAQ30833756-D45370A6-6D9D-4945-A6D3-E6191D275D45Q33936313-FCF1C6B7-9ABF-4014-962F-C01BDE0D7554Q34800764-305D09B9-AFB4-46FE-8206-55B0C76F25D1Q35150107-40E13E08-BE33-4CDA-904F-FE661BD9650CQ36103852-910FD014-58D8-4F0B-A6F0-70D8BC8208DBQ36201549-3B38FF74-CFE5-4866-89A3-0BBE85AFD05AQ36239744-0B70D73B-FEED-4214-A06A-A641162A1EABQ36239750-F39C7BFB-1549-4016-A337-B6B24E5F6CB9Q36631479-CC087499-AB04-40BA-8EFB-7126E167F12DQ36668326-AEFDC1F9-C749-41D0-8FDA-A7A37E50E177Q36686125-0E1D6F90-815E-4966-B564-4C1232568FABQ36777965-B93DC954-302C-469A-852C-281411615600Q36943999-804B9608-4BA3-4732-A845-AD1B8DFEE130Q37965607-8D0AF63E-1901-4947-BF87-323B4588CB3FQ38033192-74E72E24-7802-4CCC-98E5-C12CBE37DA6DQ38223153-9FF80747-603C-4C21-A02F-17FCAEB9E2CFQ38577923-64B9235F-45FB-4CE9-8AE1-5124F7661E90Q38867934-B89A2D10-6133-4ACF-8DC2-90B7C6B0F9FEQ38878252-8F5236B5-F00D-47CB-8173-DB392DFC42AEQ38974412-4C03B6A9-9B2D-4147-9782-0F81FC7E8DB6Q39548613-A90D69D3-73FF-4D17-AC0F-A0A064C1E09BQ40062985-79789010-4B23-4DF4-840A-0770873EEC61Q41750470-8FE7ED74-D9A1-4452-AE45-2FFDE485E990Q41994963-9D0FEED1-AEEB-424C-B576-1447F5731244Q43434203-26BFC268-0C5A-4A60-A33F-4034D6BD9BF6Q43624976-E0C365EF-50CF-4FAF-AC40-3D951FAE2BCBQ45939131-E2F87DB7-1144-4811-BD60-FDF1267ECDB7Q56533852-9127803A-B180-4601-94D2-A9F1D2786A6EQ58602774-592F2BD8-D70A-4D23-AFFB-E3F638DB6E7E
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Risk factors associated with onychomycosis.
@en
Risk factors associated with onychomycosis.
@nl
type
label
Risk factors associated with onychomycosis.
@en
Risk factors associated with onychomycosis.
@nl
prefLabel
Risk factors associated with onychomycosis.
@en
Risk factors associated with onychomycosis.
@nl
P2860
P1476
Risk factors associated with onychomycosis.
@en
P2093
Sigurgeirsson B
Steingrímsson O
P2860
P356
10.1111/J.1468-3083.2004.00851.X
P577
2004-01-01T00:00:00Z